Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications

J Zielonka, J Joseph, A Sikora, M Hardy… - Chemical …, 2017 - ACS Publications
Mitochondria are recognized as one of the most important targets for new drug design in
cancer, cardiovascular, and neurological diseases. Currently, the most effective way to …

Cancer stem cell metabolism

M Peiris-Pagès, UE Martinez-Outschoorn… - Breast Cancer …, 2016 - Springer
Cancer is now viewed as a stem cell disease. There is still no consensus on the metabolic
characteristics of cancer stem cells, with several studies indicating that they are mainly …

Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy

W Zhang, X Hu, Q Shen, D Xing - Nature communications, 2019 - nature.com
Cancer cells exhibit slightly elevated levels of reactive oxygen species (ROS) compared with
normal cells, and approximately 90% of intracellular ROS is produced in mitochondria. In …

[HTML][HTML] Mitochondrial channels: ion fluxes and more

I Szabo, M Zoratti - Physiological reviews, 2014 - journals.physiology.org
The field of mitochondrial ion channels has recently seen substantial progress, including the
molecular identification of some of the channels. An integrative approach using genetics …

Mitochondria-targeted small molecule therapeutics and probes

RAJ Smith, RC Hartley, MP Murphy - Antioxidants & redox signaling, 2011 - liebertpub.com
Significance: Mitochondrial function is central to a wide range of biological processes in
health and disease and there is considerable interest in developing small molecules that are …

Classification of mitocans, anti-cancer drugs acting on mitochondria

J Neuzil, LF Dong, J Rohlena, J Truksa, SJ Ralph - Mitochondrion, 2013 - Elsevier
Mitochondria have emerged as an intriguing target for anti-cancer drugs, inherent to vast
majority if not all types of tumours. Drugs that target mitochondria and exert anti-cancer …

The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer

J Zhou, WY Zhao, X Ma, RJ Ju, XY Li, N Li, MG Sun… - Biomaterials, 2013 - Elsevier
Lung cancer is the leading cause of cancer-related death in humans and the multidrug
resistance (MDR) is the major obstacle to successful chemotherapy of lung cancer. In this …

The role of tumor microenvironment on cancer stem cell fate in solid tumors

S Razi, A Haghparast, S Chodari Khameneh… - Cell Communication and …, 2023 - Springer
In the last few decades, the role of cancer stem cells in initiating tumors, metastasis,
invasion, and resistance to therapies has been recognized as a potential target for tumor …

[HTML][HTML] The mitochondrial permeability transition pore in AD 2016: An update

L Biasutto, M Azzolini, I Szabo, M Zoratti - Biochimica et Biophysica Acta …, 2016 - Elsevier
Over the past 30 years the mitochondrial permeability transition–the permeabilization of the
inner mitochondrial membrane due to the opening of a wide pore–has progressed from …

Mitochondrial membrane potential and reactive oxygen species in cancer stem cells

B Zhang, D Wang, F Guo, C Xuan - Familial cancer, 2015 - Springer
Cancer stem cells (CSCs) are believed as the initiators of the occurrence, development and
recurrence of malignant tumors. Targeting this unique cell population would provide a less …